148 related articles for article (PubMed ID: 1356517)
1. Comparison of PCNA/cyclin immunohistochemistry with flow cytometric S-phase fraction in breast cancer.
Visscher DW; Wykes S; Kubus J; Crissman JD
Breast Cancer Res Treat; 1992; 22(2):111-8. PubMed ID: 1356517
[TBL] [Abstract][Full Text] [Related]
2. Multiparametric deoxyribonucleic acid and cell cycle analysis of breast carcinomas by flow cytometry. Clinicopathologic correlations.
Visscher DW; Zarbo RJ; Jacobsen G; Kambouris A; Talpos G; Sakr W; Crissman JD
Lab Invest; 1990 Mar; 62(3):370-8. PubMed ID: 1690316
[TBL] [Abstract][Full Text] [Related]
3. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
[TBL] [Abstract][Full Text] [Related]
4. Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry.
Dawson AE; Norton JA; Weinberg DS
Am J Pathol; 1990 May; 136(5):1115-24. PubMed ID: 1972000
[TBL] [Abstract][Full Text] [Related]
5. Ki-67 and proliferating cell nuclear antigen tumor proliferative indices in DNA diploid colorectal adenocarcinomas. Correlation with histopathologic characteristics and cell cycle analysis with two-color DNA flow cytometry.
Linden MD; Ma CK; Kubus J; Brown RD; Zarbo RJ
Am J Clin Pathol; 1993 Sep; 100(3):206-12. PubMed ID: 8104388
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric evaluation of flow cytometric synthesis phase fraction determination in dual-labelled breast carcinomas.
Visscher DW; Wykes S; Zarbo RJ; Crissman JD
Anal Quant Cytol Histol; 1991 Aug; 13(4):246-52. PubMed ID: 1718294
[TBL] [Abstract][Full Text] [Related]
7. A comparison of proliferation markers and their prognostic value for women with endometrial carcinoma. Ki-67, proliferating cell nuclear antigen, and flow cytometric S-phase fraction.
Nordström B; Strang P; Bergström R; Nilsson S; Tribukait B
Cancer; 1996 Nov; 78(9):1942-51. PubMed ID: 8909315
[TBL] [Abstract][Full Text] [Related]
8. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
Larsson P
Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
[TBL] [Abstract][Full Text] [Related]
9. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
Tanioka F; Hiroi M; Yamane T; Hara H
Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
[TBL] [Abstract][Full Text] [Related]
10. Intratumor variation in cell proliferation in breast carcinoma as determined by antiproliferating cell nuclear antigen monoclonal antibody and automated image analysis.
Siitonen SM; Isola JJ; Rantala IS; Helin HJ
Am J Clin Pathol; 1993 Mar; 99(3):226-31. PubMed ID: 8095363
[TBL] [Abstract][Full Text] [Related]
11. Proliferating-cell nuclear antigen (PC10) immunolabelling and other proliferation indices as prognostic factors in breast cancer.
Aaltomaa S; Lipponen P; Papinaho S; Syrjänen K
J Cancer Res Clin Oncol; 1993; 119(5):288-94. PubMed ID: 8095051
[TBL] [Abstract][Full Text] [Related]
12. Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score.
Tahan SR; Neuberg DS; Dieffenbach A; Yacoub L
Cancer; 1993 Jun; 71(11):3552-9. PubMed ID: 8098267
[TBL] [Abstract][Full Text] [Related]
13. The expression of proliferating cell nuclear antigen in paraffin sections of peripheral, node-negative non-small cell lung cancer.
Fontanini G; Macchiarini P; Pepe S; Ruggiero A; Hardin M; Bigini D; Vignati S; Pingitore R; Angeletti CA
Cancer; 1992 Sep; 70(6):1520-7. PubMed ID: 1355398
[TBL] [Abstract][Full Text] [Related]
14. Reproducibility in DNA flow cytometric analysis of breast cancer: comparison of 12 laboratories' results for 67 sample homogenates.
Baldetorp B; Bendahl PO; Fernö M; Alanen K; Delle U; Falkmer U; Hansson-Aggesjö B; Höckenström T; Lindgren A; Mossberg L
Cytometry; 1995 Jun; 22(2):115-27. PubMed ID: 7587742
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of the combined assessment of proliferating cell nuclear antigen immunostaining and nuclear DNA content in invasive human mammary carcinomas.
Schimmelpenning H; Eriksson ET; Franzén B; Zetterberg A; Auer GU
Virchows Arch A Pathol Anat Histopathol; 1993; 423(4):273-9. PubMed ID: 7901939
[TBL] [Abstract][Full Text] [Related]
16. The proliferative fraction in lymph nodes: a comparison of proliferating cell nuclear antigen morphometry to flow cytometry.
Krauss JS; Pantazis CG; Chandler FW
Ann Clin Lab Sci; 1992; 22(3):189-96. PubMed ID: 1354428
[TBL] [Abstract][Full Text] [Related]
17. Correlations of morphology, proliferation indices, and oncogene activation in ductal breast carcinoma: nuclear grade, S-phase, proliferating cell nuclear antigen, p53, epidermal growth factor receptor, and c-erb-B-2.
Dabbs DJ
Mod Pathol; 1995 Aug; 8(6):637-42. PubMed ID: 8532697
[TBL] [Abstract][Full Text] [Related]
18. Comparison between Ki-67 index and S-phase fraction on fine-needle aspiration samples from breast carcinoma.
Bozzetti C; Nizzoli R; Camisa R; Guazzi A; Ceci G; Cocconi G; Mazzini G; Naldi N
Cancer; 1997 Oct; 81(5):287-92. PubMed ID: 9349516
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness.
Gasparini G; Pozza F; Meli S; Reitano M; Santini G; Bevilacqua P
Anticancer Res; 1991; 11(6):2015-21. PubMed ID: 1776834
[TBL] [Abstract][Full Text] [Related]
20. Proliferating cell nuclear antigen in archival surgical specimens of malignant lymphoma and metastatic carcinoma: immunohistochemical and flow cytometric analysis.
Gorczyca W; Kram A; Tuziak T; Darzynkiewicz Z; Melamed MR
Patol Pol; 1993; 44(3):121-8. PubMed ID: 7902557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]